Pharmaceutical

Nutrigenomics Market is predicted to reach a valuation of USD 17,313.5 Million by 2023 growing at a 16.8% CAGR from 2019 to 2023. It studies the effect of food and their constituents on the genes. The major factors contributing for the growth of the market are rising diabetic and obese population, increasing applications in dermatology, and increasing demand for advanced diagnostic methods. According to the International Diabetes Federation (2016), 420 million adults were suffering from diabetes which is expected to reach 625 million by 2040